HemaSphere (Aug 2023)
P1279: OUTCOMES OF AUTOLOGOUS STEM CELL TRANSPLANT IN PATIENTS WITH MULTIPLE MYELOMA WITH TWO OR MORE HIGH-RISK CYTOGENETIC ABNORMALITIES
- Oren Pasvolsky,
- Sassine Ghanem,
- Denái R. Milton,
- Adeel Masood,
- Mark R. Tanner,
- Qaiser Bashir,
- Samer Srour,
- Neeraj Saini,
- Jeremy L. Ramdial,
- Yago Nieto,
- Hans C. Lee,
- Krina K. Patel,
- Partow Kebriaei,
- Sheeba K. Thomas,
- Donna M. Weber,
- Robert Z. Orlowski,
- Elizabeth J. Shpall,
- Richard E. Champlin,
- Muzaffar H. Qazilbash
Affiliations
- Oren Pasvolsky
- 1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States
- Sassine Ghanem
- 4 Alpert Medical School of Brown University, Department of Medicine, Providence, United States
- Denái R. Milton
- 5 The University of Texas MD Anderson Cancer Center, Department of Biostatistics, Houston, United States
- Adeel Masood
- 1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States
- Mark R. Tanner
- 1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States
- Qaiser Bashir
- 1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States
- Samer Srour
- 1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States
- Neeraj Saini
- 1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States
- Jeremy L. Ramdial
- 1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States
- Yago Nieto
- 1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States
- Hans C. Lee
- 6 The University of Texas MD Anderson Cancer Center, Department of Lymphoma & Myeloma, Houston, United States
- Krina K. Patel
- 6 The University of Texas MD Anderson Cancer Center, Department of Lymphoma & Myeloma, Houston, United States
- Partow Kebriaei
- 1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States
- Sheeba K. Thomas
- 6 The University of Texas MD Anderson Cancer Center, Department of Lymphoma & Myeloma, Houston, United States
- Donna M. Weber
- 6 The University of Texas MD Anderson Cancer Center, Department of Lymphoma & Myeloma, Houston, United States
- Robert Z. Orlowski
- 6 The University of Texas MD Anderson Cancer Center, Department of Lymphoma & Myeloma, Houston, United States
- Elizabeth J. Shpall
- 1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States
- Richard E. Champlin
- 1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States
- Muzaffar H. Qazilbash
- 1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States
- DOI
- https://doi.org/10.1097/01.HS9.0000972004.30708.e8
- Journal volume & issue
-
Vol. 7
p. e30708e8
Abstract
No abstracts available.